1952 — Everest Medicines Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for Everest Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4,481	2,640	1,651	2,350	1,603
Net Total Accounts Receivable
Net Total Receivables	10.9	19.6	1,687	132	388
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4,496	2,688	3,414	2,508	2,016
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	122	288	724	685	651
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	7,477	6,646	6,615	5,773	4,959
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	187	270	870	300	794
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	636	754	960	804	886
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	6,841	5,892	5,654	4,969	4,073
Total Liabilities & Shareholders' Equity	7,477	6,646	6,615	5,773	4,959
Total Common Shares Outstanding